These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 20233507)

  • 1. In vitro and in vivo characterization of novel biodegradable polymers for application as drug-eluting stent coatings.
    Lockwood NA; Hergenrother RW; Patrick LM; Stucke SM; Steendam R; Pacheco E; Virmani R; Kolodgie FD; Hubbard B
    J Biomater Sci Polym Ed; 2010; 21(4):529-52. PubMed ID: 20233507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Promising Approach for Improving the Coating Stability and In Vivo Performance of Biodegradable Polymer-Coated Sirolimus-Eluting Stent.
    Bedair TM; Kang SN; Joung YK; Han DK
    J Biomed Nanotechnol; 2016 Nov; 12(11):2015-28. PubMed ID: 29364616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating.
    Jabara R; Chronos N; Robinson K
    Catheter Cardiovasc Interv; 2008 Aug; 72(2):186-94. PubMed ID: 18651646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel polymer-free paclitaxel-eluting stent with a nanoporous surface for rapid endothelialization and inhibition of intimal hyperplasia: Comparison with a polymer-based sirolimus-eluting stent and bare metal stent in a porcine model.
    Jia H; Liu H; Kong J; Hou J; Wu J; Zhang M; Tian J; Liu H; Ma L; Hu S; Huang X; Zhang S; Zhang S; Yu B; Jang IK
    J Biomed Mater Res A; 2011 Sep; 98(4):629-37. PubMed ID: 21732525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lowering the dose of sirolimus, released from a nonpolymeric hydroxyapatite coated coronary stent, reduces signs of delayed healing.
    van der Giessen WJ; Sorop O; Serruys PW; Peters-Krabbendam I; van Beusekom HM
    JACC Cardiovasc Interv; 2009 Apr; 2(4):284-90. PubMed ID: 19463438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SYNERGY biodegradable polymer everolimus eluting coronary stent: Porcine vascular compatibility and polymer safety study.
    Wilson GJ; Marks A; Berg KJ; Eppihimer M; Sushkova N; Hawley SP; Robertson KA; Knapp D; Pennington DE; Chen YL; Foss A; Huibregtse B; Dawkins KD
    Catheter Cardiovasc Interv; 2015 Nov; 86(6):E247-57. PubMed ID: 26009986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Nuclear Magnetic Resonance Spectroscopy as a Method for Evaluation of In Vivo Poly-l-Lactide Biodegradation Kinetics From Stent-Polymer Matrices: An Experimental Study Utilizing Porcine Model of In-Stent Restenosis.
    Orlik B; Buszman PP; Krauze A; Gąsior P; Desperak P; Pająk J; Kasperczyk J; Janas A; Jelonek M; Handzlik-Orlik G; Buszman PE; Milewski K
    J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):93-9. PubMed ID: 25944843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Supralimus sirolimus-eluting stent.
    Lemos PA; Bienert I
    Expert Rev Med Devices; 2013 May; 10(3):295-300. PubMed ID: 23597097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface Modification of Biodegradable Polymers towards Better Biocompatibility and Lower Thrombogenicity.
    Rudolph A; Teske M; Illner S; Kiefel V; Sternberg K; Grabow N; Wree A; Hovakimyan M
    PLoS One; 2015; 10(12):e0142075. PubMed ID: 26641662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix.
    Granada JF; Inami S; Aboodi MS; Tellez A; Milewski K; Wallace-Bradley D; Parker S; Rowland S; Nakazawa G; Vorpahl M; Kolodgie FD; Kaluza GL; Leon MB; Virmani R
    Circ Cardiovasc Interv; 2010 Jun; 3(3):257-66. PubMed ID: 20442358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a novel biocompatible polymer system for extended drug release in a next-generation drug-eluting stent.
    Udipi K; Chen M; Cheng P; Jiang K; Judd D; Caceres A; Melder RJ; Wilcox JN
    J Biomed Mater Res A; 2008 Jun; 85(4):1064-71. PubMed ID: 17937416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo performance of a dual drug-eluting stent (DDES).
    Huang Y; Venkatraman SS; Boey FY; Lahti EM; Umashankar PR; Mohanty M; Arumugam S; Khanolkar L; Vaishnav S
    Biomaterials; 2010 May; 31(15):4382-91. PubMed ID: 20189244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized polymer coating for magnesium alloy-based bioresorbable scaffolds for long-lasting drug release and corrosion resistance.
    Xu W; Yagoshi K; Koga Y; Sasaki M; Niidome T
    Colloids Surf B Biointerfaces; 2018 Mar; 163():100-106. PubMed ID: 29284158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating concepts.
    Steigerwald K; Merl S; Kastrati A; Wieczorek A; Vorpahl M; Mannhold R; Vogeser M; Hausleiter J; Joner M; Schömig A; Wessely R
    Biomaterials; 2009 Feb; 30(4):632-7. PubMed ID: 18990438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo characterisation of biodegradable polymer-based drug-eluting stent.
    Yazdani SK; Vorpahl M; Nakano M; Su SH; Kolodgie FD; Virmani R
    EuroIntervention; 2011 Nov; 7(7):835-43. PubMed ID: 22082579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes.
    Han Y; Jing Q; Xu B; Yang L; Liu H; Shang X; Jiang T; Li Z; Zhang H; Li H; Qiu J; Liu Y; Li Y; Chen X; Gao R;
    JACC Cardiovasc Interv; 2009 Apr; 2(4):303-9. PubMed ID: 19463441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of long-term implantation of BuMA stent in a porcine coronary model.
    Chen M; Wang XG; Zheng B; Peng HY; Zhang XY; Zhang B; Huo Y
    Chin Med J (Engl); 2012 Nov; 125(22):4083-7. PubMed ID: 23158147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual drug-eluting stents coated with multilayers of hydrophobic heparin and sirolimus.
    Su LC; Chen YH; Chen MC
    ACS Appl Mater Interfaces; 2013 Dec; 5(24):12944-53. PubMed ID: 24294944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.